Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Earnings Preview: What to Expect From Moderna's Report

Moderna is all set to release its fiscal third-quarter earnings next month, and analysts project its loss to rise in double digits.

Nvidia's 84% Expected Profit Growth Looms Large In S&P 500

Nvidia's 84% Expected Profit Growth Looms Large In S&P 500

Nvidia is expected to boost the S&P 500 Q3 earnings growth rate. Meta Platforms and Alphabet may lift Communications Services earnings.

Investors Business Daily

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Missed Nvidia? 10 Other S&P 500 Stocks Will Make You Much Richer

It's hard not to love Nvidia — given its huge run this year. But analysts think you can do much better with other S&P 500 stocks.

Investors Business Daily

It's time to roll up sleeves for new COVID, flu shots

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines

The Independent UK

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Midday stock movers: Adobe, Boeing, Moderna

Here are the stocks making the biggest market moves.

inkl

Read news from The Economist, FT, and more,
with one subscription

Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day

Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day

Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.

Investors Business Daily

Cancer vaccine breakthrough as tests show positive results on patients with tumours

Cancer vaccine breakthrough as tests show positive results on patients with tumours

The jab, known as mRNA-4359, is developed by Moderna

The Independent UK

Stock Market Today: Stocks Rise in Choppy Day for Markets

Stock Market Today: Stocks Rise in Choppy Day for Markets

Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.

Midday stock movers: Kroger, Alaska Air, Moderna

Midday stock movers: Kroger, Alaska Air, Moderna

Here are the stocks making the biggest market moves.

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Dow Jones Rallies Late As Nasdaq, Nvidia Clear Important Chart Levels (Live Coverage)

Dow Jones Rallies Late As Nasdaq, Nvidia Clear Important Chart Levels (Live Coverage)

Indexes were mixed in the stock market today after inflation showed signs of easing. Nvidia cleared a key level after analysts made it a top pick.

Investors Business Daily

Moderna Crashes After Slashing Its R&D Budget, Issuing Light Guidance

Moderna Crashes After Slashing Its R&D Budget, Issuing Light Guidance

Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget and issued a light sales view.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Is Moderna Stock Underperforming the Nasdaq?

While Moderna has underperformed the broader Nasdaq index in 2024, analysts are reasonably bullish about the stock's potential.

Stocks Finish Higher on Support From Chip Stock Rebound

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.30%. Stocks on Monday posted moderate gains on some dip buying following last Friday’s sharp...

The Conversation

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

Stocks Climb on Strength in Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off on some...

Get all your
news in one place.

100’s of premium titles.
One news app.

Stocks Move Higher on Strength in Chip Stocks and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.11%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off as chip...

International Business Times

Moderna MRNA Mpox Vaccine Shows Promise In Animal Study

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease symptoms and duration, according to an animal study published in the journal Cell on Wednesday.

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

The Independent UK

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

Updated COVID mRNA Vaccines Get FDA Approval: Here's What To Know

The updated COVID shots from Pfizer-BioNTech and Moderna target the current KP.2 strain of SARS-CoV-2, a descendant of the highly contagious Omicron subvariant JN.1.

New COVID vaccines approved early

New shots from Pfizer and Moderna will be available within days. Here's how to get yours

People

Demetre Daskalakis

Stéphane Bancel

Robert Hopkins Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

250,690 stories

105,051 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play